Literature DB >> 1509232

Polymerase chain reaction with double primer pairs for detection of human parvovirus B19 induced aplastic crises in family outbreaks.

E Fridell1, A N Békássy, B Larsson, B M Eriksson.   

Abstract

Parvovirus B19 DNA can be detected by polymerase chain reaction with double primer pairs (nested PCR). Recent infection was documented by a retrospective serological study using Parvoscan-B19 enzyme linked immunosorbent assay (EIA) for detection of B19 human parvovirus IgM and IgG antibodies in serum or plasma specimens. In 3 families B19 outbreaks caused aplastic crises necessitating blood transfusion in 5 children and 1 adult with hereditary sphaerocytosis. Four members from 2 of the families had clinically overt haemolytic anaemia prior to the event. Two members in another family presented with an aplastic crisis disclosing the underlying chronic haemolytic disease. All 7 patients were identified as PCR positive in serum samples taken 3-14 days after the onset of symptoms. Comparison with dot blot hybridization revealed detectable DNA in only 2/3 PCR positive patients. Thus, nested PCR is more sensitive than the dot blot hybridization method and is therefore a suitable complement to the antibody assay for identifying recent B19 infection.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1509232     DOI: 10.3109/00365549209061332

Source DB:  PubMed          Journal:  Scand J Infect Dis        ISSN: 0036-5548


  2 in total

1.  Increased risk of parvovirus B19 infection in young adult cancer patients receiving multiple courses of chemotherapy.

Authors:  Sung-Hsin Kuo; Liang-In Lin; Chee-Jen Chang; Yun-Ru Liu; Kuo-Sin Lin; Ann-Lii Cheng
Journal:  J Clin Microbiol       Date:  2002-11       Impact factor: 5.948

2.  Simultaneous detection of measles virus, rubella virus, and parvovirus B19 by using multiplex PCR.

Authors:  María del Mar Mosquera; Fernando de Ory; Mónica Moreno; Juan E Echevarría
Journal:  J Clin Microbiol       Date:  2002-01       Impact factor: 5.948

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.